Evaluation of the Expression of the Inhibitor of Apoptosis Protein Family and Human Telomerase Reverse Transcriptase in Patients With Advanced Colorectal Adenoma
It has been reported that the expression of the inhibitor of apoptosis protein (IAP) family increases in patients with colon cancer. We evaluated the expression of the IAP family and human telomerase reverse transcriptase (hTERT) in normal colon mucosa from patients with advanced colorectal adenoma...
Saved in:
| Published in | Journal of cancer prevention Vol. 22; no. 2; pp. 98 - 102 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Korea (South)
Korean Society of Cancer Prevention
01.06.2017
대한암예방학회 |
| Subjects | |
| Online Access | Get full text |
| ISSN | 2288-3649 2288-3657 |
| DOI | 10.15430/JCP.2017.22.2.98 |
Cover
| Abstract | It has been reported that the expression of the inhibitor of apoptosis protein (IAP) family increases in patients with colon cancer. We evaluated the expression of the IAP family and human telomerase reverse transcriptase (hTERT) in normal colon mucosa from patients with advanced colorectal adenoma and investigated their features according to characteristics of advanced colorectal adenoma.
While resections of polyps were performed in patients (n = 80) diagnosed with advanced colorectal adenoma or carcinoma in situ, additional normal tissues were obtained from the sigmoid colon. In healthy patients (n = 16), blind biopsies were performed on the sigmoid colon. The expression of the IAP family, including survivin, XIAP, cIAP1, and cIAP2, and hTERT, were analyzed by real-time PCR in both groups.
A total of 80 advanced colorectal adenoma patients (71.3% male, mean age of 60.4 years) and 16 control patients were enrolled in this study. The mean ranking of cIAP2 was higher in the control group (68.88 vs. 44.43,
= 0.001). The expression levels of hTERT, survivin, XIAP, and cIAP from both groups showed no differences. The expression of survivin, XIAP, cIAP1, cIAP2, and hTERT depending on certain factors of advanced adenoma, including the number (two or fewer vs. three or more), size (smaller than 1 cm vs. larger than 1 cm), grade of dysplasia (low grade adenoma vs. high grade adenoma), pathology (tubular adenoma vs. villous adenoma), and presence of endometrial intraepithelial neoplasms, showed no significant correlations in the Mann-Whitney U-test.
The expression of the IAP family and hTERT, except cIAP2, in the normal mucosa of patients with advanced colorectal adenoma were not different from those of the control group. There were no differences in the IAP family and hTERT according to the characteristics of advanced adenoma. |
|---|---|
| AbstractList | Background: It has been reported that the expression of the inhibitor of apoptosis protein (IAP) family increases in patients with colon cancer. We evaluated the expression of the IAP family and human telomerase reverse transcriptase (hTERT) in normal colon mucosa from patients with advanced colorectal adenoma and investigated their features according to characteristics of advanced colorectal adenoma.
Methods: While resections of polyps were performed in patients (n = 80) diagnosed with advanced colorectal adenoma or carcinoma in situ, additional normal tissues were obtained from the sigmoid colon. In healthy patients (n = 16), blind biopsies were performed on the sigmoid colon. The expression of the IAP family, including survivin, XIAP, cIAP1, and cIAP2, and hTERT, were analyzed by real-time PCR in both groups.
Results: A total of 80 advanced colorectal adenoma patients (71.3% male, mean age of 60.4 years) and 16 control patients were enrolled in this study. The mean ranking of cIAP2 was higher in the control group (68.88 vs. 44.43, P = 0.001). The expression levels of hTERT, survivin, XIAP, and cIAP from both groups showed no differences. The expression of survivin, XIAP, cIAP1, cIAP2, and hTERT depending on certain factors of advanced adenoma, including the number (two or fewer vs. three or more), size (smaller than 1 cm vs. larger than 1 cm), grade of dysplasia (low grade adenoma vs. high grade adenoma), pathology (tubular adenoma vs. villous adenoma), and presence of endometrial intraepithelial neoplasms, showed no significant correlations in the Mann-Whitney U-test.
Conclusions: The expression of the IAP family and hTERT, except cIAP2, in the normal mucosa of patients with advanced colorectal adenoma were not different from those of the control group. There were no differences in the IAP family and hTERT according to the characteristics of advanced adenoma. KCI Citation Count: 0 It has been reported that the expression of the inhibitor of apoptosis protein (IAP) family increases in patients with colon cancer. We evaluated the expression of the IAP family and human telomerase reverse transcriptase (hTERT) in normal colon mucosa from patients with advanced colorectal adenoma and investigated their features according to characteristics of advanced colorectal adenoma. While resections of polyps were performed in patients (n = 80) diagnosed with advanced colorectal adenoma or carcinoma in situ, additional normal tissues were obtained from the sigmoid colon. In healthy patients (n = 16), blind biopsies were performed on the sigmoid colon. The expression of the IAP family, including survivin, XIAP, cIAP1, and cIAP2, and hTERT, were analyzed by real-time PCR in both groups. A total of 80 advanced colorectal adenoma patients (71.3% male, mean age of 60.4 years) and 16 control patients were enrolled in this study. The mean ranking of cIAP2 was higher in the control group (68.88 vs. 44.43, = 0.001). The expression levels of hTERT, survivin, XIAP, and cIAP from both groups showed no differences. The expression of survivin, XIAP, cIAP1, cIAP2, and hTERT depending on certain factors of advanced adenoma, including the number (two or fewer vs. three or more), size (smaller than 1 cm vs. larger than 1 cm), grade of dysplasia (low grade adenoma vs. high grade adenoma), pathology (tubular adenoma vs. villous adenoma), and presence of endometrial intraepithelial neoplasms, showed no significant correlations in the Mann-Whitney U-test. The expression of the IAP family and hTERT, except cIAP2, in the normal mucosa of patients with advanced colorectal adenoma were not different from those of the control group. There were no differences in the IAP family and hTERT according to the characteristics of advanced adenoma. It has been reported that the expression of the inhibitor of apoptosis protein (IAP) family increases in patients with colon cancer. We evaluated the expression of the IAP family and human telomerase reverse transcriptase (hTERT) in normal colon mucosa from patients with advanced colorectal adenoma and investigated their features according to characteristics of advanced colorectal adenoma.BACKGROUNDIt has been reported that the expression of the inhibitor of apoptosis protein (IAP) family increases in patients with colon cancer. We evaluated the expression of the IAP family and human telomerase reverse transcriptase (hTERT) in normal colon mucosa from patients with advanced colorectal adenoma and investigated their features according to characteristics of advanced colorectal adenoma.While resections of polyps were performed in patients (n = 80) diagnosed with advanced colorectal adenoma or carcinoma in situ, additional normal tissues were obtained from the sigmoid colon. In healthy patients (n = 16), blind biopsies were performed on the sigmoid colon. The expression of the IAP family, including survivin, XIAP, cIAP1, and cIAP2, and hTERT, were analyzed by real-time PCR in both groups.METHODSWhile resections of polyps were performed in patients (n = 80) diagnosed with advanced colorectal adenoma or carcinoma in situ, additional normal tissues were obtained from the sigmoid colon. In healthy patients (n = 16), blind biopsies were performed on the sigmoid colon. The expression of the IAP family, including survivin, XIAP, cIAP1, and cIAP2, and hTERT, were analyzed by real-time PCR in both groups.A total of 80 advanced colorectal adenoma patients (71.3% male, mean age of 60.4 years) and 16 control patients were enrolled in this study. The mean ranking of cIAP2 was higher in the control group (68.88 vs. 44.43, P = 0.001). The expression levels of hTERT, survivin, XIAP, and cIAP from both groups showed no differences. The expression of survivin, XIAP, cIAP1, cIAP2, and hTERT depending on certain factors of advanced adenoma, including the number (two or fewer vs. three or more), size (smaller than 1 cm vs. larger than 1 cm), grade of dysplasia (low grade adenoma vs. high grade adenoma), pathology (tubular adenoma vs. villous adenoma), and presence of endometrial intraepithelial neoplasms, showed no significant correlations in the Mann-Whitney U-test.RESULTSA total of 80 advanced colorectal adenoma patients (71.3% male, mean age of 60.4 years) and 16 control patients were enrolled in this study. The mean ranking of cIAP2 was higher in the control group (68.88 vs. 44.43, P = 0.001). The expression levels of hTERT, survivin, XIAP, and cIAP from both groups showed no differences. The expression of survivin, XIAP, cIAP1, cIAP2, and hTERT depending on certain factors of advanced adenoma, including the number (two or fewer vs. three or more), size (smaller than 1 cm vs. larger than 1 cm), grade of dysplasia (low grade adenoma vs. high grade adenoma), pathology (tubular adenoma vs. villous adenoma), and presence of endometrial intraepithelial neoplasms, showed no significant correlations in the Mann-Whitney U-test.The expression of the IAP family and hTERT, except cIAP2, in the normal mucosa of patients with advanced colorectal adenoma were not different from those of the control group. There were no differences in the IAP family and hTERT according to the characteristics of advanced adenoma.CONCLUSIONSThe expression of the IAP family and hTERT, except cIAP2, in the normal mucosa of patients with advanced colorectal adenoma were not different from those of the control group. There were no differences in the IAP family and hTERT according to the characteristics of advanced adenoma. |
| Author | Shin, Cheol Min Kim, Nayoung Lee, Dong Ho Park, Young Soo Choi, Joon Young Choi, Yoon Jin Yoon, Hyuk |
| AuthorAffiliation | 2 Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea 1 Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea |
| AuthorAffiliation_xml | – name: 1 Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea – name: 2 Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea |
| Author_xml | – sequence: 1 givenname: Joon Young surname: Choi fullname: Choi, Joon Young organization: Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea – sequence: 2 givenname: Hyuk surname: Yoon fullname: Yoon, Hyuk organization: Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea – sequence: 4 givenname: Yoon Jin surname: Choi fullname: Choi, Yoon Jin organization: Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea – sequence: 5 givenname: Cheol Min surname: Shin fullname: Shin, Cheol Min organization: Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea – sequence: 6 givenname: Young Soo surname: Park fullname: Park, Young Soo organization: Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea – sequence: 7 givenname: Nayoung surname: Kim fullname: Kim, Nayoung organization: Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea, Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea – sequence: 8 givenname: Dong Ho surname: Lee fullname: Lee, Dong Ho organization: Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28698863$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002239261$$DAccess content in National Research Foundation of Korea (NRF) |
| BookMark | eNp1UstuEzEUHaEiWko_gA3yki4y-DEPe4MURSkNqkRUBbG0PJ47xHTGHmxPRD-HP8VJ2qogsbr28XnIuud1dmKdhSx7S3BOyoLhD58X65xiUueU5jQX_EV2RinnM1aV9cnTuRCn2UUIPzDGhJWVEPRVdkp5JTiv2Fn2e7lT_aSicRa5DsUtoOWv0UMIz5CV3ZrGROf3wHx0Y3TBBLT2LoKx6EoNpr9HyrboehqURRvo3QBeBUC3sAOf5sYrG7Q3Y9yjSbROmWBjQN9M3KJ5u1NWQ4sWrncedFR9wsC6Qb3JXnaqD3DxMM-zr1fLzeJ6dvPl02oxv5lpVrE40xVrG9Up1jJV6o50mnBccV43FJjANeuIooJxqBqq06WBDmte1kUNJROEsPPs8uhrfSfvtJFOmcP87uSdl_PbzUoSJgqC99yPR-44NQO0On3Eq16O3gzK3x-Uf79Ys00-O1mWmFG6N3j_YODdzwlClIMJGvpeWXBTkEQQzjgtC5qo755nPYU87jAR6iNBexeCh05qEw8bTdGmlwTLQ2FkKozcF0ZSKqkUPCnJP8pH8_9r_gChtsYg |
| CitedBy_id | crossref_primary_10_3390_molecules28135082 crossref_primary_10_3892_mco_2023_2657 crossref_primary_10_31083_j_fbl2912421 |
| Cites_doi | 10.1016/0168-9525(96)30018-8 10.3322/caac.21262 10.3892/ijmm.10.2.205 10.1111/j.1349-7006.2009.01112.x 10.3892/ijo.21.3.493 10.1002/ijc.22416 10.1007/s10495-007-0087-3 10.1002/jso.21408 10.1007/s00595-010-4390-1 10.1016/j.cell.2007.10.030 10.1016/j.ceb.2006.08.015 10.1080/00313020701716425 10.1038/scientificamerican0296-92 10.2174/156652411797536723 10.1016/j.humpath.2005.09.022 10.1126/science.7605428 |
| ContentType | Journal Article |
| Copyright | Copyright © 2017 Korean Society of Cancer Prevention 2017 |
| Copyright_xml | – notice: Copyright © 2017 Korean Society of Cancer Prevention 2017 |
| DBID | AAYXX CITATION NPM 7X8 5PM ACYCR |
| DOI | 10.15430/JCP.2017.22.2.98 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Korean Citation Index |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2288-3657 |
| EndPage | 102 |
| ExternalDocumentID | oai_kci_go_kr_ARTI_1394101 PMC5503221 28698863 10_15430_JCP_2017_22_2_98 |
| Genre | Journal Article |
| GroupedDBID | 5-W 8JR AAYXX ADBBV ADRAZ ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CITATION DIK HYE KQ8 M48 OK1 PGMZT RPM NPM 7X8 5PM ACYCR |
| ID | FETCH-LOGICAL-c363t-c63dbafa3d3a5cf1fc1806887b2e39073f1a2938e6b2c3f1bef0c85747e539113 |
| IEDL.DBID | M48 |
| ISSN | 2288-3649 |
| IngestDate | Tue Nov 21 21:42:21 EST 2023 Thu Aug 21 17:17:19 EDT 2025 Thu Jul 10 23:36:40 EDT 2025 Thu Jan 02 22:22:29 EST 2025 Thu Apr 24 23:11:05 EDT 2025 Tue Jul 01 00:34:53 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | Telomerase Inhibitor of apoptosis proteins Colonic neoplasm |
| Language | English |
| License | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c363t-c63dbafa3d3a5cf1fc1806887b2e39073f1a2938e6b2c3f1bef0c85747e539113 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.15430/JCP.2017.22.2.98 |
| PMID | 28698863 |
| PQID | 1918382542 |
| PQPubID | 23479 |
| PageCount | 5 |
| ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_1394101 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5503221 proquest_miscellaneous_1918382542 pubmed_primary_28698863 crossref_citationtrail_10_15430_JCP_2017_22_2_98 crossref_primary_10_15430_JCP_2017_22_2_98 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2017-06-01 |
| PublicationDateYYYYMMDD | 2017-06-01 |
| PublicationDate_xml | – month: 06 year: 2017 text: 2017-06-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Korea (South) |
| PublicationPlace_xml | – name: Korea (South) |
| PublicationTitle | Journal of cancer prevention |
| PublicationTitleAlternate | J Cancer Prev |
| PublicationYear | 2017 |
| Publisher | Korean Society of Cancer Prevention 대한암예방학회 |
| Publisher_xml | – name: Korean Society of Cancer Prevention – name: 대한암예방학회 |
| References | ref13 ref12 ref15 ref14 ref11 ref10 ref2 ref1 ref17 ref16 ref18 ref8 ref7 ref9 ref4 ref3 ref6 ref5 12119560 - Int J Mol Med. 2002 Aug;10(2):205-10 7605428 - Science. 1994 Dec 23;266(5193):2011-5 19777490 - J Surg Oncol. 2009 Dec 15;100(8):708-12 25651787 - CA Cancer J Clin. 2015 Mar;65(2):87-108 17154176 - Int J Cancer. 2007 Mar 1;120(5):1081-6 18038311 - Pathology. 2008 Jan;40(1):25-30 8560215 - Sci Am. 1996 Feb;274(2):92-7 8901415 - Trends Genet. 1996 Apr;12(4):129-31 21264751 - Surg Today. 2011 Feb;41(2):175-82 21902653 - Curr Mol Med. 2011 Nov;11(8):633-49 16360419 - Hum Pathol. 2006 Jan;37(1):78-86 17573556 - Apoptosis. 2007 Sep;12 (9):1543-68 8460509 - West J Med. 1993 Mar;158(3):273-8 16934447 - Curr Opin Cell Biol. 2006 Dec;18(6):609-15 12168091 - Int J Oncol. 2002 Sep;21(3):493-7 19639203 - Oncol Rep. 2009 Sep;22(3):557-62 19302291 - Cancer Sci. 2009 May;100(5):903-13 18022362 - Cell. 2007 Nov 16;131(4):669-81 |
| References_xml | – ident: ref9 doi: 10.1016/0168-9525(96)30018-8 – ident: ref4 – ident: ref1 doi: 10.3322/caac.21262 – ident: ref6 – ident: ref16 doi: 10.3892/ijmm.10.2.205 – ident: ref2 doi: 10.1111/j.1349-7006.2009.01112.x – ident: ref15 doi: 10.3892/ijo.21.3.493 – ident: ref18 doi: 10.1002/ijc.22416 – ident: ref5 doi: 10.1007/s10495-007-0087-3 – ident: ref11 doi: 10.1002/jso.21408 – ident: ref12 doi: 10.1007/s00595-010-4390-1 – ident: ref3 doi: 10.1016/j.cell.2007.10.030 – ident: ref14 doi: 10.1016/j.ceb.2006.08.015 – ident: ref17 doi: 10.1080/00313020701716425 – ident: ref7 doi: 10.1038/scientificamerican0296-92 – ident: ref10 doi: 10.2174/156652411797536723 – ident: ref13 doi: 10.1016/j.humpath.2005.09.022 – ident: ref8 doi: 10.1126/science.7605428 – reference: 21264751 - Surg Today. 2011 Feb;41(2):175-82 – reference: 19639203 - Oncol Rep. 2009 Sep;22(3):557-62 – reference: 12119560 - Int J Mol Med. 2002 Aug;10(2):205-10 – reference: 18038311 - Pathology. 2008 Jan;40(1):25-30 – reference: 21902653 - Curr Mol Med. 2011 Nov;11(8):633-49 – reference: 7605428 - Science. 1994 Dec 23;266(5193):2011-5 – reference: 16360419 - Hum Pathol. 2006 Jan;37(1):78-86 – reference: 17573556 - Apoptosis. 2007 Sep;12 (9):1543-68 – reference: 19777490 - J Surg Oncol. 2009 Dec 15;100(8):708-12 – reference: 8560215 - Sci Am. 1996 Feb;274(2):92-7 – reference: 12168091 - Int J Oncol. 2002 Sep;21(3):493-7 – reference: 18022362 - Cell. 2007 Nov 16;131(4):669-81 – reference: 8460509 - West J Med. 1993 Mar;158(3):273-8 – reference: 16934447 - Curr Opin Cell Biol. 2006 Dec;18(6):609-15 – reference: 17154176 - Int J Cancer. 2007 Mar 1;120(5):1081-6 – reference: 25651787 - CA Cancer J Clin. 2015 Mar;65(2):87-108 – reference: 8901415 - Trends Genet. 1996 Apr;12(4):129-31 – reference: 19302291 - Cancer Sci. 2009 May;100(5):903-13 |
| SSID | ssj0001356992 |
| Score | 2.0141304 |
| Snippet | It has been reported that the expression of the inhibitor of apoptosis protein (IAP) family increases in patients with colon cancer. We evaluated the... Background: It has been reported that the expression of the inhibitor of apoptosis protein (IAP) family increases in patients with colon cancer. We evaluated... |
| SourceID | nrf pubmedcentral proquest pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 98 |
| SubjectTerms | Original 예방의학 |
| Title | Evaluation of the Expression of the Inhibitor of Apoptosis Protein Family and Human Telomerase Reverse Transcriptase in Patients With Advanced Colorectal Adenoma |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/28698863 https://www.proquest.com/docview/1918382542 https://pubmed.ncbi.nlm.nih.gov/PMC5503221 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002239261 |
| Volume | 22 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | 대한암예방학회지, 2017, 22(2), , pp.98-102 |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1db9MwFLW28cILAvEVGJNBPCGlNHbiOg8IVVWnbdJQhVaxN8t2bBqtJF2SSePn8E-5N0kjigpPUZzv3Ovrc5ybewh5HxujExf5EIKjD2ObJaFGNXfAps7GE2myGP9GvvwizpbxxXVyfUC28lb9C6z3UjvUk1pW69H97c_P0OE_teo9MR9_vJgtMElrMmJsxEapPCQPYGASyMUue7TfTrnwRKStTDJj4B9cxGn_nXPvWbBOsBSplILvDFqHReX34dG_0yr_GKdOH5NHPcCk084jnpADVzwlv-ZDUW9aegqgj87v-xTYoeW8WOUGOniFDdNNuWnKOq_pAis55AXtJDKoLjLazvzTK7cucUqrdvSrw-wOR9uRr41D2AoHLbqyrTX9ljcrOu0TDugMQi6GWrxRCHzlD_2MLE_nV7OzsBdnCC0XvAmt4JnRXvOM68T6yNtIooDNxDDHgXFzH2mAEtIJwyysGOfHVibAXlzCIcLy5-SoKAv3klDtAPSkmgspsthxk7rMp4BdjDRW-NQFZLx9-8r2lctRQGOtkMGg7RTYTqHtFGOKqVQG5MNwyKYr2_G_nd-BSdWNzRUW28bl91LdVAooxbkCiBxD3ArI263FFfRA_KyiC1fe1QoYr-RItFlAXnQeMFxz60ABmez4xrADXnB3S5Gv2irfQB0h2Eav_nnO1-QhPkWXt3ZMjprqzr0BhNSYk9bvT9qpq99dUA68 |
| linkProvider | Scholars Portal |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluation+of+the+Expression+of+the+Inhibitor+of+Apoptosis+Protein+Family+and+Human+Telomerase+Reverse+Transcriptase+in+Patients+With+Advanced+Colorectal+Adenoma&rft.jtitle=Journal+of+cancer+prevention&rft.au=Choi%2C+Joon+Young&rft.au=Yoon%2C+Hyuk&rft.au=Na%2C+Gyeongjae&rft.au=Choi%2C+Yoon+Jin&rft.date=2017-06-01&rft.issn=2288-3649&rft.volume=22&rft.issue=2&rft.spage=98&rft_id=info:doi/10.15430%2FJCP.2017.22.2.98&rft_id=info%3Apmid%2F28698863&rft.externalDocID=28698863 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2288-3649&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2288-3649&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2288-3649&client=summon |